Microbiology & Immunology - Research Publications

Permanent URI for this collection

Search Results

Now showing 1 - 10 of 27
  • Item
    Thumbnail Image
    CD8 coreceptor engagement of MR1 enhances antigen responsiveness by human MAIT and other MR1-reactive T cells
    Souter, MNT ; Awad, W ; Li, S ; Pediongco, T ; Meehan, BS ; Meehan, LJ ; Tian, Z ; Zhao, Z ; Wang, H ; Nelson, A ; Le Nours, J ; Khandokar, Y ; Praveena, T ; Wubben, J ; Lin, J ; Sullivan, LC ; Lovrecz, G ; Mak, JYW ; Liu, L ; Kostenko, L ; Kedzierska, K ; Corbett, AJ ; Fairlie, DP ; Brooks, AG ; Gherardin, NA ; Uldrich, AP ; Chen, Z ; Rossjohn, J ; Godfrey, DI ; MCCLUSKEY, J ; Pellicci, DG ; Eckle, SBG (Rockefeller University Press, 2022)
    Mucosal-associated invariant T (MAIT) cells detect microbial infection via recognition of riboflavin-based antigens presented by the major histocompatibility complex class I (MHC-I)-related protein 1 (MR1). Most MAIT cells in human peripheral blood express CD8αα or CD8αβ coreceptors, and the binding site for CD8 on MHC-I molecules is relatively conserved in MR1. Yet, there is no direct evidence of CD8 interacting with MR1 or the functional consequences thereof. Similarly, the role of CD8αα in lymphocyte function remains ill-defined. Here, using newly developed MR1 tetramers, mutated at the CD8 binding site, and by determining the crystal structure of MR1-CD8αα, we show that CD8 engaged MR1, analogous to how it engages MHC-I molecules. CD8αα and CD8αβ enhanced MR1 binding and cytokine production by MAIT cells. Moreover, the CD8-MR1 interaction was critical for the recognition of folate-derived antigens by other MR1-reactive T cells. Together, our findings suggest that both CD8αα and CD8αβ act as functional coreceptors for MAIT and other MR1-reactive T cells.
  • Item
    No Preview Available
    CD36 family members are TCR-independent ligands for CD1 antigen-presenting molecules.
    Gherardin, NA ; Redmond, SJ ; McWilliam, HEG ; Almeida, CF ; Gourley, KHA ; Seneviratna, R ; Li, S ; De Rose, R ; Ross, FJ ; Nguyen-Robertson, CV ; Su, S ; Ritchie, ME ; Villadangos, JA ; Moody, DB ; Pellicci, DG ; Uldrich, AP ; Godfrey, DI (American Association for the Advancement of Science, 2021-06-25)
    CD1c presents lipid-based antigens to CD1c-restricted T cells, which are thought to be a major component of the human T cell pool. However, the study of CD1c-restricted T cells is hampered by the presence of an abundantly expressed, non-T cell receptor (TCR) ligand for CD1c on blood cells, confounding analysis of TCR-mediated CD1c tetramer staining. Here, we identified the CD36 family (CD36, SR-B1, and LIMP-2) as ligands for CD1c, CD1b, and CD1d proteins and showed that CD36 is the receptor responsible for non-TCR-mediated CD1c tetramer staining of blood cells. Moreover, CD36 blockade clarified tetramer-based identification of CD1c-restricted T cells and improved identification of CD1b- and CD1d-restricted T cells. We used this technique to characterize CD1c-restricted T cells ex vivo and showed diverse phenotypic features, TCR repertoire, and antigen-specific subsets. Accordingly, this work will enable further studies into the biology of CD1 and human CD1-restricted T cells.
  • Item
    Thumbnail Image
    Total Synthesis of Mycobacterium tuberculosis Dideoxymy-cobactin-838 and Stereoisomers: Diverse CD1a-Restricted T Cells Display a Common Hierarchy of Lipopeptide Recognition
    Cheng, JMH ; Liu, L ; Pellicci, DG ; Reddiex, SJJ ; Cotton, RN ; Cheng, T-Y ; Young, DC ; Van Rhijn, I ; Moody, DB ; Rossjohn, J ; Fairlie, DP ; Godfrey, DI ; Williams, SJ (WILEY-V C H VERLAG GMBH, 2017-01)
    Mycobacterium tuberculosis produces dideoxymycobactin-838 (DDM-838), a lipopeptide that potently activates T cells upon binding to the MHC-like antigen-presenting molecule CD1a. M. tuberculosis produces DDM-838 in only trace amounts and a previous solid-phase synthesis provided sub-milligram quantities. We describe a high-yielding solution-phase synthesis of DDM-838 that features a Mitsunobu substitution that avoids yield-limiting epimerization at lysine during esterification, and amidation conditions that prevent double-bond isomerization of the Z-C20:1 acyl chain, and provides material with equivalent antigenicity to natural DDM-838. Isomers of DDM-838 that varied in stereochemistry at the central lysine and the C20:1 acyl chain were compared for their ability to be recognised by CD1a-restricted T cell receptors (TCRs). These TCRs, derived from unrelated human donors, exhibited a similar spectrum of reactivity towards the panel of DDM-838 isomers, highlighting the exquisite sensitivity of lipopeptide-reactive T cells for the natural DDM stereochemistry.
  • Item
    Thumbnail Image
    Characterization of Human Mucosal-associated Invariant T (MAIT) Cells
    Souter, MNT ; Loh, L ; Li, S ; Meehan, BS ; Gherardin, NA ; Godfrey, DI ; Rossjohn, J ; Fairlie, DP ; Kedzierska, K ; Pellicci, DG ; Chen, Z ; Kjer-Nielsen, L ; Corbett, AJ ; McCluskey, J ; Eckle, SBG (Wiley-Blackwell, 2019)
    Mucosal‐associated invariant T (MAIT) cells are a subset of unconventional T cells restricted by the major histocompatibility complex (MHC) class I–like molecule MHC‐related protein 1 (MR1). MAIT cells are found throughout the body, especially in human blood and liver. Unlike conventional T cells, which are stimulated by peptide antigens presented by MHC molecules, MAIT cells recognize metabolite antigens derived from an intermediate in the microbial biosynthesis of riboflavin. MAIT cells mediate protective immunity to infections by riboflavin‐producing microbes via the production of cytokines and cytotoxicity. The discovery of stimulating MAIT cell antigens allowed for the development of an analytical tool, the MR1 tetramer, that binds specifically to the MAIT T cell receptor (TCR) and is becoming the gold standard for identification of MAIT cells by flow cytometry. This article describes protocols to characterize the phenotype of human MAIT cells in blood and tissues by flow cytometry using fluorescently labeled human MR1 tetramers alongside antibodies specific for MAIT cell markers.
  • Item
    Thumbnail Image
    Atypical natural killer T-cell receptor recognition of CD1d-lipid antigens
    Le Nours, J ; Praveena, T ; Pellicci, DG ; Gherardin, NA ; Ross, FJ ; Lim, RT ; Besra, GS ; Keshipeddy, S ; Richardson, SK ; Howell, AR ; Gras, S ; Godfrey, DI ; Rossjohn, J ; Uldrich, AP (NATURE PUBLISHING GROUP, 2016-02)
    Crucial to Natural Killer T (NKT) cell function is the interaction between their T-cell receptor (TCR) and CD1d-antigen complex. However, the diversity of the NKT cell repertoire and the ensuing interactions with CD1d-antigen remain unclear. We describe an atypical population of CD1d-α-galactosylceramide (α-GalCer)-reactive human NKT cells that differ markedly from the prototypical TRAV10-TRAJ18-TRBV25-1(+) type I NKT cell repertoire. These cells express a range of TCR α- and β-chains that show differential recognition of glycolipid antigens. Two atypical NKT TCRs (TRAV21-TRAJ8-TRBV7-8 and TRAV12-3-TRAJ27-TRBV6-5) bind orthogonally over the A'-pocket of CD1d, adopting distinct docking modes that contrast with the docking mode of all type I NKT TCR-CD1d-antigen complexes. Moreover, the interactions with α-GalCer differ between the type I and these atypical NKT TCRs. Accordingly, diverse NKT TCR repertoire usage manifests in varied docking strategies and specificities towards CD1d-α-GalCer and related antigens, thus providing far greater scope for diverse glycolipid antigen recognition.
  • Item
    Thumbnail Image
    Rapid loss of group 1 innate lymphoid cells during blood stage Plasmodium infection
    Ng, SS ; Souza-Fonseca-Guimaraes, F ; Rivera, FDL ; Amante, FH ; Kumar, R ; Gao, Y ; Sheel, M ; Beattie, L ; de Oca, MM ; Guillerey, C ; Edwards, CL ; Faleiro, RJ ; Frame, T ; Bunn, PT ; Vivier, E ; Godfrey, DI ; Pellicci, DG ; Lopez, JA ; Andrews, KT ; Huntington, ND ; Smyth, MJ ; McCarthy, J ; Engwerda, CR (WILEY, 2018-01-12)
    OBJECTIVES: Innate lymphoid cells (ILCs) share many characteristics with CD4+ T cells, and group 1 ILCs share a requirement for T-bet and the ability to produce IFNγ with T helper 1 (Th1) cells. Given this similarity, and the importance of Th1 cells for protection against intracellular protozoan parasites, we aimed to characterise the role of group 1 ILCs during Plasmodium infection. METHODS: We quantified group 1 ILCs in peripheral blood collected from subjects infected with with Plasmodium falciparum 3D7 as part of a controlled human malaria infection study, and in the liver and spleens of Pc AS-infected mice. We used genetically-modified mouse models, as well as cell-depletion methods in mice to characterise the role of group 1 ILCs during Pc AS infection. RESULTS: In a controlled human malaria infection study, we found that the frequencies of circulating ILC1s and NK cells decreased as infection progressed but recovered after volunteers were treated with antiparasitic drug. A similar observation was made for liver and splenic ILC1s in P. chabaudi chabaudi AS (Pc AS)-infected mice. The decrease in mouse liver ILC1 frequencies was associated with increased apoptosis. We also identified a population of cells within the liver and spleen that expressed both ILC1 and NK cell markers, indicative of plasticity between these two cell lineages. Studies using genetic and cell-depletion approaches indicated that group 1 ILCs have a limited role in antiparasitic immunity during Pc AS infection in mice. DISCUSSION: Our results are consistent with a previous study indicating a limited role for natural killer (NK) cells during Plasmodium chabaudi infection in mice. Additionally, a recent study reported the redundancy of ILCs in humans with competent B and T cells. Nonetheless, our results do not rule out a role for group 1 ILCs in human malaria in endemic settings given that blood stage infection was initiated intravenously in our experimental models, and thus bypassed the liver stage of infection, which may influence the immune response during the blood stage. CONCLUSION: Our results show that ILC1s are lost early during mouse and human malaria, and this observation may help to explain the limited role for these cells in controlling blood stage infection.
  • Item
    Thumbnail Image
    Development of mucosal-associated invariant T cells
    Koay, H-F ; Godfrey, DI ; Pellicci, DG (WILEY, 2018-07)
    Mucosal-associated invariant T (MAIT) cells develop in the thymus and migrate into the periphery to become the largest antigen-specific αβ T-cell population in the human immune system. However, the frequency of MAIT cells varies widely between human individuals, and the basis for this is unclear. While MAIT cells are highly conserved through evolution and are phenotypically similar between humans and mice, they represent a much smaller proportion of total T cells in mice. In this review, we discuss how MAIT cells transition through a three-stage development pathway in both mouse and human thymus, and continue to mature and expand after they leave the thymus. Moreover, we will explore and speculate on how specific factors regulate different stages of this process.
  • Item
    Thumbnail Image
    CD1b presents self and Borrelia burgdorferi diacylglycerols to human T cells
    Reinink, P ; Souter, MNT ; Cheng, T-Y ; van Gorkom, T ; Lenz, S ; Kubler-Kielb, J ; Strle, K ; Kremer, K ; Thijsen, SFT ; Steere, AC ; Godfrey, DI ; Pellicci, DG ; Moody, DB ; Van Rhijn, I (WILEY, 2019-05)
    Lyme disease is a common multisystem disease caused by infection with a tick-transmitted spirochete, Borrelia burgdorferi and related Borrelia species. The monoglycosylated diacylglycerol known as B. burgdorferi glycolipid II (BbGL-II) is a major target of antibodies in sera from infected individuals. Here, we show that CD1b presents BbGL-II to human T cells and that the TCR mediates the recognition. However, we did not detect increased frequency of CD1b-BbGL-II binding T cells in the peripheral blood of Lyme disease patients compared to controls. Unexpectedly, mapping the T cell specificity for BbGL-II-like molecules using tetramers and activation assays revealed a concomitant response to CD1b-expressing APCs in absence of BbGL-II. Further, among all major classes of self-lipid tested, BbGL-II responsive TCRs show strong cross-reactivity to diacylglycerol, a self-lipid antigen with structural similarities to BbGL-II. Extending prior work on MHC and CD1b, CD1c, and CD1d proteins, this study provides evidence for cross-reactive CD1b-restricted T cell responses to bacterial and self-antigens, and identifies chemically defined targets for future discovery of self and foreign antigen cross-reactive T cells.
  • Item
    Thumbnail Image
    Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors
    Almeida, CF ; Sundararaj, S ; Le Nours, J ; Praveena, T ; Cao, B ; Burugupalli, S ; Smith, DGM ; Patel, O ; Brigl, M ; Pellicci, DG ; Williams, SJ ; Uldrich, AP ; Godfrey, DI ; Rossjohn, J (NATURE PORTFOLIO, 2019-11-20)
    Type I and type II natural killer T (NKT) cells are restricted to the lipid antigen-presenting molecule CD1d. While we have an understanding of the antigen reactivity and function of type I NKT cells, our knowledge of type II NKT cells in health and disease remains unclear. Here we describe a population of type II NKT cells that recognise and respond to the microbial antigen, α-glucuronosyl-diacylglycerol (α-GlcADAG) presented by CD1d, but not the prototypical type I NKT cell agonist, α-galactosylceramide. Surprisingly, the crystal structure of a type II NKT TCR-CD1d-α-GlcADAG complex reveals a CD1d F'-pocket-docking mode that contrasts sharply with the previously determined A'-roof positioning of a sulfatide-reactive type II NKT TCR. Our data also suggest that diverse type II NKT TCRs directed against distinct microbial or mammalian lipid antigens adopt multiple recognition strategies on CD1d, thereby maximising the potential for type II NKT cells to detect different lipid antigens.
  • Item
    Thumbnail Image
    Chronically stimulated human MAIT cells are unexpectedly potent IL-13 producers
    Kelly, J ; Minoda, Y ; Meredith, T ; Cameron, G ; Philipp, M-S ; Pellicci, DG ; Corbett, AJ ; Kurts, C ; Gray, DHD ; Godfrey, D ; Kannourakis, G ; Berzins, SP (WILEY, 2019-09)
    Mucosal-associated invariant T (MAIT) cells are unconventional T cells that recognize antigens derived from riboflavin biosynthesis. In addition to anti-microbial functions, human MAIT cells are associated with cancers, autoimmunity, allergies and inflammatory disorders, although their role is poorly understood. Activated MAIT cells are well known for their rapid release of Th1 and Th17 cytokines, but we have discovered that chronic stimulation can also lead to potent interleukin (IL)-13 expression. We used RNA-seq and qRT-PCR to demonstrate high expression of the IL-13 gene in chronically stimulated MAIT cells, and directly identify IL-13 using intracellular flow cytometry and multiplex bead analysis of MAIT cell cultures. This unexpected finding has important implications for IL-13-dependent diseases, such as colorectal cancer (CRC), that occur in mucosal areas where MAIT cells are abundant. We identify MAIT cells near CRC tumors and show that these areas and precancerous polyps express high levels of the IL-13 receptor, which promotes tumor progression and metastasis. Our data suggest that MAIT cells have a more complicated role in CRC than currently realized and that they represent a promising new target for immunotherapies where IL-13 can be a critical factor.